1:03 PM
Mar 02, 2018
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Quentis debuts with $48M series A

Cancer company Quentis Therapeutics Inc. (New York, N.Y.) raised $48 million on Feb. 27 in a series A round led by existing investor Versant Ventures and new investor Polaris Partners. New investors AbbVie Ventures, Taiho Pharmaceutical Co. Ltd. (Tokyo, Japan), Yonghua Capital, Alexandria Venture Investments and New...

Read the full 213 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >